Felbamate

Specifications

25451-15-4CAS Number

247-001-4EC Number

(3-carbamoyloxy-2-phenylpropyl) carbamateIUPAC Name

C11H14N2O4Chemical Formula

238.24 g/molMolecular Weight

felbamate; 25451-15-4; Felbatol; 2-Phenyl-1,3-propanediol dicarbamate; Taloxa; Felbamato; Felbamatum; W-554; 1,3-Propanediol, 2-phenyl-, dicarbamate; ADD-03055; DTXSID9023041; W 554; carbamic acid 2-phenyltrimethylene ester; Carbamic acid, 2-phenyltrimethylene ester; 3-(carbamoyloxy)-2-phenylpropyl carbamate; NSC-759866; CHEBI:4995; X72RBB02N8; ADD 03055; DTXCID903041; 4-06-00-05993 (Beilstein Handbook Reference); Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester; ADD03055; 2 Phenyl 1,3 propanediol dicarbamate; W554; RefChem:57692; N03AX10; 247-001-4; 2-Phenylpropane-1,3-diyl dicarbamate; Felbamyl; MFCD00865296; (3-carbamoyloxy-1,1,3,3-tetradeuterio-2-phenylpropyl) carbamate; MLS000028465; s1330; Felbamatum [Latin]; NCGC00015429-08; W-554;ADD-03055; Felbamato [Spanish]; SMR000058448; Felbamate [USAN:INN]; (3-carbamoyloxy-2-phenylpropyl) carbamate; Felbatol (TN); CAS-25451-15-4; (3-carbamoyloxy-2-phenyl-propyl) carbamate; SR-01000000089; EINECS 247-001-4; BRN 3345236; UNII-X72RBB02N8; Felbamate?; HSDB 7525; Felbamate (Standard); Felbamate (USPINN); Tocris-0869; FELBAMATE [INN]; FELBAMATE [MI]; FELBAMATE [HSDB]; FELBAMATE [USAN]; 2-Phenyl-1,3-propanediol 1,3-dicarbamate; Opera_ID_1738; Prestwick0_000919; FELBAMATE [VANDF]; Lopac-F-0778; Biomol-NT_000203; FELBAMATE [MART.]; F 0778; FELBAMATE [USP-RS]; FELBAMATE [WHO-DD]; CHEMBL1094; Lopac0_000524; SCHEMBL34947; MLS001077299; BIDD:GT0463; BPBio1_001258; GTPL5473; orb1225506; orb1307014; FELBAMATE [ORANGE BOOK]; HY-B0184R; EX-A591; FELBAMATE [USP MONOGRAPH]; GLXC-06734; HMS2093P19; HMS2234H06; HMS3261J09; HMS3266L12; HMS3370I06; HMS3411P21; HMS3657I11; HMS3675P21; HMS3715D20; HMS3884E11; HMS5079H11; Pharmakon1600-01505600; HY-B0184; MSK11368; Tox21_110145; Tox21_302368; Tox21_500524; BDBM50088430; EBC-06581; NSC759866; AKOS015895100; Tox21_110145_1; AC-8197; CCG-204614; CS-2068; DB00949; KS-1171; LP00524; NSC 759866; SDCCGSBI-0050507.P003; NCGC00015429-01; NCGC00015429-02; NCGC00015429-03; NCGC00015429-04; NCGC00015429-05; NCGC00015429-06; NCGC00015429-07; NCGC00015429-09; NCGC00015429-10; NCGC00015429-11; NCGC00015429-14; NCGC00015429-19; NCGC00015429-20; NCGC00015429-24; NCGC00023092-02; NCGC00023092-04; NCGC00023092-05; NCGC00023092-06; NCGC00255275-01; NCGC00261209-01; SBI-0050507.P002; DB-046702; AE2 - Newer Anti-epileptic drug mixtures 2; EU-0100524; NS00010360; SW197633-2; C07501; D00536; EN300-119542; AB00382985-18; AB00382985_19; Q421301; SR-01000000089-2; SR-01000000089-4; SR-01000000089-7; BRD-K99107520-001-01-9; BRD-K99107520-001-09-2; BRD-K99107520-001-18-3; BRD-K99107520-001-23-3; BRD-K99107520-001-24-1; BRD-K99107520-001-25-8; Z1521554005; Felbamate, United States Pharmacopeia (USP) Reference StandardSynonyms